References

  1. Phillips LH 2nd. The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 2003;998:407-12. PubMed | Google Scholar

  2. Patrick J, Lindstrom J. Autoimmune response to acetylcholine receptors. Science. 1973 May 25;180(4088):871-2. Google Scholar

  3. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009; 8(5): 475-90. PubMed | Google Scholar

  4. Parr JR, Jayawant S. Childhood myasthenia: clinical subtypes and practical management. Dev Med Child Neurol. 2007;49(8):629-35. PubMed | Google Scholar

  5. Zhang X, Yang M, Xu J et al. Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry. 2007;78(4):386-90. PubMed | Google Scholar

  6. Heckmann JM, Hansen P, Van Toorn R, Lubbe E, Janse van Rensburg E, Wilmshurst JM. The characteristics of juvenile myasthenia gravis among South Africans. S Afr Med J. 2012 May 23;102(6):532-6. PubMed | Google Scholar

  7. Lertchavanakul A, Gamnerdsiri P, Hirunwiwatkul P. Ice test for ocular myasthenia gravis. J Med Assoc Thai. 2001;84(Suppl1):S131-6. PubMed | Google Scholar

  8. Vander Pluym J, Vajsar J, Jacob FD, Mah JK, Grenier D, KolskiH. Clinical characteristics of pediatric myasthenia : a surveillance study. Pediatrics. 2013; 132(4):e939-44. Google Scholar

  9. Alam S, Nivean PD. Early onset bilateral juvenile myasthenia gravis masquerading as simple congenital ptosis. GMS Ophthalmology Cases. 2017; 7:Doc07. Google Scholar